YONGHE MED.GR.DL-0000025

L97 · F · Healthcare / Medical Care Facilities

0.244EUR+0.00 (+0.83%)

Price History

Full chart

Market Stats

Previous Close0.242

Open0.244

Day Range0.244 – 0.244

52-Week Range0.1634 – 0.276

Volume0

Market Cap111.02M

P/E (TTM)7.40

Forward P/E0.00

EPS0.03

Dividend Yield4.27%

Beta0.57

50-Day Avg0.2368

200-Day Avg0.2141

About

Yonghe Medical Group Co., Ltd. provides hair-related healthcare services in China. The company offers hair transplant, medical hair care, routine hair restoration, and other ancillary services. It also engages in the provision of consulting services; investment and management; and medical wig products. Yonghe Medical Group Co., Ltd. was founded in 2005 and is headquartered in Beijing, China.

Company Details

SectorHealthcare
IndustryMedical Care Facilities
CEOMr. Yu Zhang
Employees3.62K
HeadquartersKunTai International Building, Beijing, China, Germany
Websitehttps://www.yonghegroup.cn

Leadership

Mr. Yu ZhangChairman of the Board & CEO · b. 1986
Ms. Zhimei HanExecutive Director, Finance Director, CFO & Joint Company Secretary · b. 1978
Mr. Hui ZhangSenior VP of the Integrated Management Center & Executive Director · b. 1988
Mr. Yang XuChief Executive Officer of Innovation Business Unit · b. 1980
Mr. Jian RenChief Growth Officer · b. 1984
Ms. Wai Kam Ng A.C.I.S., A.C.S.Joint Company Secretary

Financials

Income Statement

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	2.17B	1.41B	1.78B	1.80B	1.81B
Growth (%)	-	-34.85%	+25.80%	+1.53%	+0.21%
Cost of Revenue	588.60M	540.21M	780.07M	720.29M	614.10M
Gross Profit	1.58B	872.58M	997.19M	1.08B	1.19B
Gross Margin	72.86%	61.76%	56.11%	60.08%	66.04%
Operating Expense	1.33B	1.03B	1.45B	1.21B	1.06B
Operating Income	249.23M	-160.54M	-450.79M	-124.69M	131.73M
Operating Margin	11.49%	-11.36%	-25.36%	-6.91%	7.28%
EBITDA	-	166.43M	-196.22M	101.14M	372.15M
EBITDA Margin	-	11.78%	-11.04%	5.60%	20.58%
Net Income	120.19M	-85.86M	-546.39M	-226.34M	73.71M
Net Income Margin	5.54%	-6.08%	-30.74%	-12.54%	4.08%
R&D	14.16M	18.50M	29.28M	21.25M	19.26M
R&D as % of Total Revenue	0.65%	1.31%	1.65%	1.18%	1.07%
Interest Expense	51.95M	51.23M	54.16M	41.22M	23.03M
Interest Expense % of Total Revenue	2.40%	3.63%	3.05%	2.28%	1.27%

Balance Sheet

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	3.20B	2.93B	2.44B	1.73B	1.70B
Total Liabilities	1.50B	1.35B	1.50B	1.01B	914.47M
Total Equity	1.70B	1.59B	942.56M	714.34M	788.05M
Cash	1.57B	565.09M	603.22M	487.84M	698.99M

Cash Flow

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	437.28M	-108.56M	-17.15M	228.62M	495.53M
Capital Expenditure	190.64M	243.51M	171.31M	53.76M	18.90M
Free Cash Flow	246.64M	-352.07M	-188.47M	174.85M	476.63M
Dividends Paid	69.80M	43.16M	-	-	-
FCF to OCF	56.40%	324.31%	1098.75%	76.48%	96.19%
Dividend Paid to FCF	28.30%	-12.26%	-	-	-

Key Statistics & Ratios

Market Cap111.02M

Enterprise Value56.47M

Trailing P/E7.40

Forward P/E0.00

Price / Sales0.06

Price / Book1.00

EPS0.03

Book Value0.2151

Revenue (TTM)1.93B

Gross Profit (TTM)1.32B

EBITDA286.44M

Profit Margin6.29%

Operating Margin10.81%

Return on Equity15.47%

Return on Assets6.79%

Shares Outstanding500.11M

Shares Float109.11M

Beta0.57

Dividend Yield4.27%

Dividend Rate0.01

Payout Ratio30.94%

Dividends

20261×

0.01May 26, 2026

20221×

0.01Jun 30, 2022